MedPath
HSA Approval

BUCLIZINE TABLET 25 mg

SIN02652P

BUCLIZINE TABLET 25 mg

BUCLIZINE TABLET 25 mg

April 27, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AE01

buclizine

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

BUCLIZINE HCl

25 mg

Buclizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUCLIZINE TABLET 25 mg - HSA Approval | MedPath